USPTO trademark

Immunolight, LLC design mark 98142436

AllowedUSPTOFigurative markClass 1Class 2Class 3Class 5+2

"Design mark 98142436" is a figurative mark owned by Immunolight, LLC, filed at the USPTO on August 21, 2023. It has been allowed and covers classes 1, 2, 3, 5, 9 and 10.

Get this data via the API
Official USPTO record
Immunolight, LLC design mark 98142436 trademark as filed
As filed with the USPTO
Status
Allowed
Since October 28, 2026
Filed
August 21, 2023
Registered
Not yet
Expires
Not recorded
Application no.
98142436
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
6 classes
Ownership

Who owns Immunolight, LLC design mark 98142436

The owner and representative on file with the office.

Owner

Immunolight, LLC

Detroit, United States

Representative

J. Derek Mason

Tucker Ellis LLP

Goods and services

What the mark covers

The products and services Immunolight, LLC design mark 98142436 is filed for, grouped by Nice class.

  • Chemical additives for altering color in cosmetic preparations; substances in the nature of chemicals for use in solar cells and photovoltaic cells

  • Particulate energy converting additives for altering color in paint, pigment and colorant preparations; paint preparations in the nature of paints containing particulate energy converting additives for altering color; pigment preparations in the nature of pigments containing particulate energy converting additives for altering color; colorant preparations in the nature of colorants containing particulate energy converting additives for altering color

  • Additives for altering color in cosmetic preparations, namely, coloring preparations and non-medicated skin care preparations; cosmetic preparations

  • Pharmaceutical preparations for biological tissue regeneration; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of brain disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disease and disorders; pharmaceutical agents for treating a disease, condition, or disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; preparations for sanitization and remediation of air supply, water supply, and biological materials for medical purposes

  • Energy storage systems comprised of solar cells, photovoltaic cells and modules and any combination thereof; optical fibers for light or color transmission; optical communication networks comprised of optical fibers

  • Medical device for detection of biophotons; medical device for detection of intercellular communication; medical device for detection of intracellular communication; medical device for treating a disease, condition and disorder by detection of intercellular communication; medical device for treating a disease, condition and disorder by detection of intracellular communication; medical device for triggering of biophotons; medical device for detection of intercellular communication; medical device for triggering of intracellular communication; medical device for treating a disease, condition and disorder by triggering of intercellular communication; medical device for treating a disease, condition and disorder by triggering of intracellular communication

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 4 granted
  3. Sou extension 4 filed
  4. Sou teas extension received
  5. Notice of approval of extension request e-mailed
  6. Sou extension 3 granted
  7. Sou extension 3 filed
  8. Sou teas extension received
  9. Notice of approval of extension request e-mailed
  10. Sou extension 2 granted

10 earlier steps on the official record.

FAQ

About Immunolight, LLC design mark 98142436

Who owns the trademark "Design mark 98142436"?

The USPTO trademark "Design mark 98142436" (application 98142436) is owned by Immunolight, LLC.

What is the status of "Design mark 98142436"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Immunolight, LLC design mark 98142436 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2c04-767f-722f-a954-7ff84e47b835
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c04-767f-722f-a954-7ff84e47b835",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "98142436",
  "filing_date": "2023-08-21",
  "nice_classes": [
    1,
    2,
    3,
    5,
    9,
    10
  ],
  "owners": [
    {
      "name": "Immunolight, LLC",
      "entity_id": null
    }
  ]
}